San Francisco, June 30, 2022 – Telegraph Hill Partners (THP), a venture capital and growth equity firm dedicated to building life science and healthcare technology

The OncoSignature® test developed based on Acrivon’s AP3 platform is a first-of-its-kind spatial signature assay to identify patients most likely to respond to ACR-368, an advanced

Boulder, CO: Mosaic Biosciences (“Mosaic” or “the Company”), a protein and antibody discovery company that helps its partners identify next-generation therapies for the prevention and

MADISON, WI, USA, [05/17/2022] — Nimble Therapeutics Inc. today announced the company has achieved the first development milestone for each of several programs attached to

Marcy l’Étoile, France, April 12th 2022 – bioMérieux, a world leader in the field of in vitro diagnostics, announces that it has entered into an

The integration of TrakCel’s OCELLOS and Lash Group’s Fusion aims to improve speed-to-therapy by increasing connectivity between providers and hub patient services Conshohocken, Pa. (January

Founded by an Experienced Management Team and Built on the Reach and Infrastructure of the San Diego Blood Bank   January 24, 2022  San Diego,

MARLBOROUGH, Mass. and MINNEAPOLIS, Jan. 05, 2022 (GLOBE NEWSWIRE) — Akoya Biosciences, Inc., (NASDAQ: AKYA), The Spatial Biology Company®, and Bio-Techne (NASDAQ: TECH), a global

SALT LAKE CITY, UTAH (December 14, 2021) – Carterra, Inc. the world leader in label-free high throughput antibody screening and characterization, today announced that it has

Partnership pairs Akoya’s spatial phenotyping solutions and PathAI’s AI-based algorithms to elucidate spatial biomarker signatures for biopharma partners MARLBOROUGH, Mass., Dec. 13, 2021 (GLOBE NEWSWIRE)

Funds will accelerate commercial activity and product development initiatives Durham, NC: Cell Microsystems Inc, a developer and manufacturer of innovative products for single cell workflows,

October 4, 2021 – Mountain View, California – FOR IMMEDIATE RELEASE Specific Diagnostics today announced it has signed multi-year reagent rental agreements with two clinical